Riskpilot← Back to searchSign inGet full accessMadCo Med AB
ABActiveOrg 5591178123Lilla Högestensgatan 2Medical specialists activities · NACE 8622Est. 20170 employees
Revenue 2025
SEK 3,7M
-5% vs 2024
EBITDA margin
58.3%
-21% vs 2024
Equity ratio
85.7%
Financial strength
Net profit 2025
SEK 1M
-33% vs 2024
| Revenue | SEK 3,7M | -5% |
| EBITDA | SEK 2,2M | -21% |
| Net profit | SEK 1M | -33% |
| Total assets | SEK 5,8M | +32% |
| Equity | SEK 5M | +20% |
| Employees | 0 | — |
Legal name
MadCo Med AB
Org number
5591178123
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
3 juli 2017
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva läkarkonsultarbete, bedriva privat ÖNH-läkarmotagning, äga och förvalta värdepapper, bedriva uthyrning och underhåll av fritidshus, äga och förvalta samt driva jord- och skogsbruk samt därmed förenlig verksamhet.
Address
Lilla Högestensgatan 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 513 | 3 350 | 3 963 | 3 932 | 3 744 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 089 | 2 032 | 2 595 | 2 753 | 2 181 |
| Depreciation & amort. | −60 | −239 | −239 | −179 | −0 |
| EBIT | 1 029 | 1 793 | 2 356 | 2 574 | 2 181 |
| Net financials | — | −267 | 281 | 39 | 34 |
| Profit before tax | 654 | 911 | 1 357 | 1 932 | 1 295 |
| Tax | −136 | −188 | −279 | −398 | −267 |
| Net profit | 518 | 723 | 1 078 | 1 534 | 1 028 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 615 | 2 529 | 3 017 | 4 407 | 5 835 |
| Equity | 1 442 | 1 978 | 2 860 | 4 184 | 5 002 |
| Long-term debt | 0 | 541 | 0 | 0 | 0 |
| Short-term debt | 173 | 10 | 156 | 222 | 401 |
| Total debt | 173 | 551 | 156 | 222 | 401 |
EBITDA margin
58.3%
This company
15.8%
Market median
+269% vs market
20212025
Equity ratio
85.7%
This company
38.2%
Market median
+124% vs market
20212025
Return on equity
20.6%
This company
18.4%
Market median
+12% vs market
20212025
Net profit margin
27.5%
This company
8.1%
Market median
+240% vs market
20212025
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
20212025
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ML | Audit | 2024 |
EM Chief Executive Officer | Chief Executive Officer | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MadCo Med AB 
Utanbro Holding ABBoard members of MadCo Med AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats-Åke Lennart Andersson | Audit | 0 companies |
| Emma Matilda Madeleine Cosmo | Chief Executive Officer | 0 companies |
| Rebecca K E Hofman-Bang | Deputy Board Member | 0 companies |